Ann Pediatr Endocrinol Metab.  2014 Sep;19(3):169-173. 10.6065/apem.2014.19.3.169.

A case of thyrotoxic periodic paralysis as initial manifestation of Graves' disease in a 16-year-old Korean adolescent

Affiliations
  • 1Department of Pediatric Endocrinology, Yonsei University College of Medicine, Seoul, Korea. arema@yuhs.ac
  • 2Department of Pediatric Neprhology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism, with recurrent muscle paralysis and hypokalemia that are caused by an intracellular shift of potassium. TPP is relatively common in Asian males, but is extremely rare in children and adolescents, even for those of Asian descent. We describe a 16-year-old Korean adolescent presenting with a two-week history of episodic leg weakness in the morning. He showed sinus tachycardia, lower leg weakness, and hypokalemia. Thyroid function test showed hyperthyroidism, and thyroid ultrasonography revealed a diffuse enlarged thyroid with increased vascularity, consistent with Graves' disease. He was treated with beta-adrenergic blocker and antithyroid drugs. He has been symptom free for one year, as his hyperthyroidism has been controlled well with antithyroid drugs. TPP should be considered in children and adolescents with acute paralysis of the lower extremities and hypokalemia.

Keyword

Thyrotoxic periodic paralysis; Graves' disease; Adolescent; Korean

MeSH Terms

Adolescent*
Antithyroid Agents
Asian Continental Ancestry Group
Child
Graves Disease*
Humans
Hyperthyroidism
Hypokalemia
Leg
Lower Extremity
Male
Paralysis*
Potassium
Tachycardia, Sinus
Thyroid Function Tests
Thyroid Gland
Ultrasonography
Antithyroid Agents
Potassium

Cited by  1 articles

Thyrotoxic hypokalemic periodic paralysis due to Graves’ disease in 2 adolescents
Jung Gi Roh, Kyu Jung Park, Hae Sang Lee, Jin Soon Hwang
Ann Pediatr Endocrinol Metab. 2019;24(2):133-136.    doi: 10.6065/apem.2019.24.2.133.


Reference

1. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore). 1992; 71:109–120. PMID: 1635436.
Article
2. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J. 1967; 1:451–455. PMID: 6017520.
Article
3. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr, McManis PG. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989; 149:2597–2600. PMID: 2818118.
Article
4. Lee JI, Sohn TS, Son HS, Oh SJ, Kwon HS, Chang SA, et al. Thyrotoxic periodic paralysis presenting as polymorphic ventricular tachycardia induced by painless thyroiditis. Thyroid. 2009; 19:1433–1434. PMID: 20001723.
Article
5. Miller JD, Quillian W, Cleveland WW. Nonfamilial hypokalemic periodic paralysis and thyrotoxicosis in a 16-year-old male. Pediatrics. 1997; 100(3 Pt 1):412. PMID: 9282719.
Article
6. Wong GW, Leung TF, Lo AF, Ahuja AT, Cheng PS. Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr. 2000; 159:934. PMID: 11131357.
Article
7. Oh KW, Jeong JY, Kim JS. A case of thyrotoxic periodic paralysis in adolescent with Graves' disease. J Korean Soc Pediatr Endocrinol. 2011; 16:196–200.
Article
8. Ahn MB, Jung YJ, Lee MH, Cho WK, Suh BK. A case of thyrotoxic periodic paralysis in a 16-year-old adolescent. Ann Pediatr Endocrinol Metab. 2012; 17:117–121.
Article
9. Azuma KK, Hensley CB, Tang MJ, McDonough AA. Thyroid hormone specifically regulates skeletal muscle Na(+)-K(+)-ATPase alpha 2- and beta 2-isoforms. Am J Physiol. 1993; 265(3 Pt 1):C680–C687. PMID: 8214025.
Article
10. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ. 1991; 303:1096–1099. PMID: 1660744.
Article
11. Kjeldsen K, Norgaard A, Gotzsche CO, Thomassen A, Clausen T. Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet. 1984; 2:8–10. PMID: 6145984.
Article
12. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis. 2001; 37:620–623. PMID: 11228188.
Article
13. Guerra M, Rodriguez del Castillo A, Battaner E, Mas M. Androgens stimulate preoptic area Na+, K+-ATPase activity in male rats. Neurosci Lett. 1987; 78:97–100. PMID: 3039424.
14. Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006; 91:2490–2495. PMID: 16608889.
15. Chang CC, Cheng CJ, Sung CC, Chiueh TS, Lee CH, Chau T, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol. 2013; 169:529–536. PMID: 23939916.
Article
16. Trifanescu RA, Danciulescu Miulescu R, Carsote M, Poiana C. Hypokalemic periodic paralysis as first sign of thyrotoxicosis. J Med Life. 2013; 6:72–75. PMID: 23599824.
17. Valizadeh N, Zarrin S. A 32-year-old man with normokalemic thyrotoxic periodic paralysis. Malays J Med Sci. 2013; 20:81–83. PMID: 23613659.
18. Lin SH, Chiu JS, Hsu CW, Chau T. A simple and rapid approach to hypokalemic paralysis. Am J Emerg Med. 2003; 21:487–491. PMID: 14574658.
Article
19. Ahmed I, Chilimuri SS. Fatal dysrhythmia following potassium replacement for hypokalemic periodic paralysis. West J Emerg Med. 2010; 11:57–59. PMID: 20411077.
20. Cope TE, Samaraweera AP, Burn DJ. Thyrotoxic periodic paralysis: correct hypokalemia with caution. J Emerg Med. 2013; 45:338–340. PMID: 23849367.
Article
Full Text Links
  • APEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr